Evaluation of an Investigational Multi-Purpose Solution (MPS)
NCT ID: NCT00961051
Last Updated: 2014-01-07
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
270 participants
INTERVENTIONAL
2009-02-28
2009-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of a New Abbott Medical Optics (AMO) Multi-Purpose Solution (MPS) to Existing Contact Lens Regimens
NCT01294917
Comfort and Cleaning Evaluation of Multipurpose Solutions in Contact Lens Patients
NCT00519948
Acute Clinical Evaluation of Multi-purpose Solutions (MPS) in Soft Contact Lens Wearers
NCT00929487
Comfort Evaluation of a New MPS vs. Replenish in Contact Lens Patients
NCT00518700
Comparative Evaluation of Corneal Staining With Balafilcon A Lenses and Two Multi-Purpose Solutions
NCT01024855
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Investigational MPS
Investigational multipurpose disinfecting solution (study MPS)
Investigational MPS
Multi-purpose solution
Predicate MPS
Opti-Free RepleniSH multipurpose disinfecting solution (predicate MPS)
Opti-Free
Multi-purpose solution
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Investigational MPS
Multi-purpose solution
Opti-Free
Multi-purpose solution
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have normal eyes (with the exception of unaided visual acuity)
* Have successfully used a multi-purpose contact lens care solution
* Have acceptable visual acuity and lens wearing comfort at time of enrollment
Exclusion Criteria
* Have a known sensitivity to any study product ingredient(s)
* Have a condition that may put them at significant risk
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Optics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicholas Tarantino, OD
Role: STUDY_CHAIR
Abbott Medical Optics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Complete Family Vision Center
San Diego, California, United States
Eye Care Associates of Hawaii
Waipahu, Hawaii, United States
Insight Eyecare
Warrensburg, Missouri, United States
Drs. Quinn, Quinn & Associates
Athens, Ohio, United States
Western Reserve Vision Care
Beachwood, Ohio, United States
Central Ohio Eyecare
Columbus, Ohio, United States
Northeastern Eye Institute
Scranton, Pennsylvania, United States
West Bay Eye Associates
Warwick, Rhode Island, United States
Ziegler Leffingwell Eyecare
West Allis, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COBR-105-9608
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.